SCHEMBL28690150

SCHEMBL28690150

O=C(Nc1ncc(-c2ccoc2)[nH]1)c1cc(-c2ccccc2)nc2ccccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 3/20 0.61
▸ CYP3A4 P08684 5/20 0.55
▸ MEN1 O00255 4/20 0.53
▸ KMT2A Q03164 4/20 0.53
▸ HPGD P15428 2/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ USP2 O75604 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ GFER P55789 1/20 0.51
▸ MAPT P10636 3/20 0.50
▸ PTGER4 P35408 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ ME2 P23368 1/20 0.50
▸ ME1 P48163 1/20 0.50
▸ ME3 Q16798 1/20 0.50
▸ CYP2C9 P11712 2/20 0.49
▸ TACR3 P29371 1/20 0.47
▸ HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28681436 0.84 STAT3 (0.61) STAT3CYP3A4MEN1KMT2AHPGD
SCHEMBL28931959 0.84 STAT3 (0.59) STAT3CYP3A4MEN1KMT2AHPGD
SCHEMBL28672666 0.84 CYP2C9 (0.68) CYP3A4MEN1KMT2AHPGDKDM4E
SCHEMBL28691066 0.82 CYP3A4 (0.68) CYP3A4MEN1KMT2AHPGDKDM4E
SCHEMBL28699070 0.81 MAPT (0.57) CYP3A4MEN1KMT2AHPGDKDM4E
SCHEMBL28695985 0.79 STAT3 (0.55) STAT3CYP3A4MEN1KMT2AHPGD
SCHEMBL28680454 0.79 TP53 (0.55) CYP3A4MEN1KMT2AHPGDKDM4E
SCHEMBL28673399 0.79 MEN1 (0.58) STAT3MEN1KMT2AHPGDKDM4E
SCHEMBL28699068 0.79 STAT3 (0.54) STAT3MEN1KMT2AHPGDKDM4E
SCHEMBL28699093 0.78 CTDSP1 (0.62) STAT3MEN1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113747920-A Immune checkpoint inhibitor combination therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-12-03 — — CN disclosed
Send feedback